Related Experiment Video
Updated: Jul 15, 2025

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300
Alexandra D Brown1, Kyle Lynch1, David N Langelaan2
1Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
Abstract:
The microphthalmia-associated transcription factor (MITF) is one of four closely related members of the MiT/TFE family (TFEB, TFE3, TFEC) that regulate a wide range of cellular processes. MITF is a key regulator of melanocyte-associated genes, and essential to proper development of the melanocyte cell lineage. Abnormal MITF activity can contribute to the onset of several diseases including melanoma, where MITF is an amplified oncogene. To enhance transcription, MITF recruits the co-activator CREB-binding protein (CBP) and its homolog p300 to gene promoters, however the molecular determinants of their interaction are not yet fully understood. Here, we characterize the interactions between the C-terminal MITF transactivation domain and CBP/p300. Using NMR spectroscopy, protein pulldown assays, and isothermal titration calorimetry we determine the C-terminal region of MITF is intrinsically disordered and binds with high-affinity to both TAZ1 and TAZ2 of CBP/p300. Mutagenesis studies revealed two conserved motifs within MITF that are necessary for TAZ2 binding and critical for MITF-dependent transcription of a reporter gene. Finally, we observe the transactivation potential of the MITF C-terminal region is reliant on the N-terminal transactivation domain for function. Taken together, our study helps elucidate the molecular details of how MITF interacts with CBP/p300 through multiple redundant interactions that lend insight into MITF function in melanocytes and melanoma.
Insights
The microphthalmia-associated transcription factor (MITF) interacts with CBP/p300 co-activators via its intrinsically disordered C-terminal region. This interaction, involving specific MITF motifs, is crucial for MITF-driven gene transcription in melanocytes and melanoma.
Area of Science:
- Molecular biology
- Cellular biology
- Biochemistry
Background:
- The microphthalmia-associated transcription factor (MITF) is vital for melanocyte development and function.
- Dysregulated MITF activity is implicated in diseases like melanoma, where it acts as an oncogene.
- MITF recruits CREB-binding protein (CBP) and p300 co-activators to gene promoters to enhance transcription.
Purpose of the Study:
- To characterize the molecular interactions between the MITF C-terminal transactivation domain and the co-activators CBP/p300.
- To identify the specific regions and motifs within MITF critical for binding to CBP/p300.
- To understand how these interactions contribute to MITF-mediated gene transcription.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy to analyze protein structure and interactions.
- Protein pulldown assays to confirm binding between MITF and CBP/p300.
- Isothermal titration calorimetry (ITC) to quantify binding affinity.
- Mutagenesis studies to identify key functional motifs in MITF.
Main Results:
- The C-terminal region of MITF is intrinsically disordered and binds with high affinity to both TAZ1 and TAZ2 domains of CBP/p300.
- Two conserved motifs within MITF were identified as essential for TAZ2 binding and MITF-dependent transcription.
- The transactivation capability of the MITF C-terminal region depends on the presence of the N-terminal transactivation domain.
Conclusions:
- MITF utilizes multiple, redundant interactions within its C-terminal region to bind CBP/p300.
- These findings elucidate the molecular mechanisms underlying MITF-coactivator interactions.
- The study provides insights into MITF function in normal melanocytes and its role in melanoma pathogenesis.
Related Concept Videos
Co-activators and Co-repressors
Master Transcription Regulators
TGF - β Signaling Pathway
Cooperative Binding of Transcription Regulators
RNA Polymerase II Accessory Proteins
MAPK Signaling Cascades

